BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19124498)

  • 1. Menopausal hormone therapy and risk of colorectal cancer.
    Johnson JR; Lacey JV; Lazovich D; Geller MA; Schairer C; Schatzkin A; Flood A
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):196-203. PubMed ID: 19124498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
    Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
    Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
    Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of menopausal hormones and risk of colorectal cancer (United States).
    Troisi R; Schairer C; Chow WH; Schatzkin A; Brinton LA; Fraumeni JF
    Cancer Causes Control; 1997 Mar; 8(2):130-8. PubMed ID: 9134236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone use and risk for colorectal cancer and adenoma.
    Grodstein F; Martinez ME; Platz EA; Giovannucci E; Colditz GA; Kautzky M; Fuchs C; Stampfer MJ
    Ann Intern Med; 1998 May; 128(9):705-12. PubMed ID: 9556463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
    Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
    Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
    JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study.
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck A; Danforth KN; Park Y; Brinton LA
    Br J Cancer; 2012 Sep; 107(7):1181-7. PubMed ID: 22929888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.
    Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; de Lange T; Bagnardi V; Ursin G; Weiderpass E
    BMJ Open; 2017 Nov; 7(11):e017639. PubMed ID: 29146641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
    Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone replacement therapy and risk of ovarian cancer.
    Lacey JV; Mink PJ; Lubin JH; Sherman ME; Troisi R; Hartge P; Schatzkin A; Schairer C
    JAMA; 2002 Jul; 288(3):334-41. PubMed ID: 12117398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
    Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
    Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.
    Tsilidis KK; Allen NE; Key TJ; Sanjoaquin MA; Bakken K; Berrino F; Fournier A; Lund E; Overvad K; Olsen A; Tjønneland A; Byrnes G; Chajes V; Rinaldi S; Boutron-Ruault MC; Clavel-Chapelon F; Chang-Claude J; Kaaks R; Bergmann M; Boeing H; Koumantaki Y; Palli D; Pala V; Panico S; Tumino R; Vineis P; Bas Bueno-de-Mesquita H; van Duijnhoven FJ; van Gils CH; Peeters PH; Rodríguez L; González CA; Sánchez MJ; Chirlaque MD; Barricarte A; Dorronsoro M; Khaw KT; Rodwell SA; Norat T; Romaguera D; Riboli E
    Int J Cancer; 2011 Apr; 128(8):1881-9. PubMed ID: 20533550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different menopausal hormone regimens and risk of breast cancer.
    Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
    Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
    Sponholtz TR; Palmer JR; Rosenberg LA; Hatch EE; Adams-Campbell LL; Wise LA
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):558-565. PubMed ID: 29475971
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone replacement therapy and endometrial cancer risk: a meta-analysis.
    Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D
    Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of postmenopausal hormone use and ovarian cancer risk.
    Danforth KN; Tworoger SS; Hecht JL; Rosner BA; Colditz GA; Hankinson SE
    Br J Cancer; 2007 Jan; 96(1):151-6. PubMed ID: 17179984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.
    Grodstein F; Newcomb PA; Stampfer MJ
    Am J Med; 1999 May; 106(5):574-82. PubMed ID: 10335731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.